CSIMarket Company Name, Ticker, Suppliers, else..
 
Cadrenal Therapeutics Inc  (NASDAQ: CVKD)
 

Cadrenal Therapeutics Inc's Suppliers Performance

CVKD's Supply Chain



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

 
CVKD Costs vs Sales of Suppliers Growth

• More on CVKD Suppliers






Cadrenal Therapeutics Inc's Comment on Supply Chain


Suppliers and manufacturing sites for tecarfarin are located outside the United States. The company intends to contract third-party contract development and manufacturing organizations (CDMOs) for drug substance and product supply related to drug candidates acquired from eXIthera and Veralox; however, no contracts are currently in place. Materials and substances used in the product candidates are sourced from a limited number of suppliers, and changing suppliers may involve significant costs and delays. If approved by the FDA, the company plans to enter agreements with third parties for manufacturing and distribution on commercially reasonable terms.

Cadrenal Therapeutics Inc's Comment on Supply Chain


Suppliers and manufacturing sites for tecarfarin are located outside the United States. The company intends to contract third-party contract development and manufacturing organizations (CDMOs) for drug substance and product supply related to drug candidates acquired from eXIthera and Veralox; however, no contracts are currently in place. Materials and substances used in the product candidates are sourced from a limited number of suppliers, and changing suppliers may involve significant costs and delays. If approved by the FDA, the company plans to enter agreements with third parties for manufacturing and distribution on commercially reasonable terms.







CVKD's vs. Suppliers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)



COMPANY NAME MARKET CAP REVENUES INCOME EMPLOYEES
Cadrenal Therapeutics Inc 3.85 0.00 -12.71 5
SUBTOTAL 0.00 0.00 0.00 -


Sources: Cadrenal Therapeutics Inc's official press releases and regulatory filings; CSIMarket.com's supply-chain research; and the financial filings and press releases of other companies cited in this report.
Updated on:
For your research, we’ve provided nine additional tables on Cadrenal Therapeutics Inc’s suppliers.
You can find them in the navigation menu under Suppliers.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.